Applied Molecular Transport Reports Third Quarter 2023 Financial Results
SOUTH SAN FRANCISCO, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a biopharmaceutical company, today reported financial results for the third quarter ended September 30, 2023.
- Cash and Cash Equivalents of $18.1 million, as of September 30, 2023
SOUTH SAN FRANCISCO, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a biopharmaceutical company, today reported financial results for the third quarter ended September 30, 2023. - Total R&D expenses for the third quarter of 2023 were $0.3 million, compared to $18.2 million for the same period in 2022.
- Total G&A expenses for the third quarter of 2023 were $7.0 million, compared to $7.3 million for the same period in 2022.
- Net loss for the third quarter of 2023 was $6.9 million, compared to $25.2 million for the same period in 2022.